Fulgent Genetics, Inc. (FLGT)
NASDAQ: FLGT · Real-Time Price · USD
14.57
-0.06 (-0.41%)
Mar 9, 2026, 2:04 PM EDT - Market open
Fulgent Genetics Revenue
In the year 2025, Fulgent Genetics had annual revenue of $322.67M with 13.83% growth. Fulgent Genetics had revenue of $83.34M in the quarter ending December 31, 2025, with 9.34% growth.
Revenue (ttm)
$322.67M
Revenue Growth
+13.83%
P/S Ratio
1.40
Revenue / Employee
$245,377
Employees
1,315
Market Cap
455.03M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 322.67M | 39.20M | 13.83% |
| Dec 31, 2024 | 283.47M | -5.74M | -1.99% |
| Dec 31, 2023 | 289.21M | -329.76M | -53.27% |
| Dec 31, 2022 | 618.97M | -373.62M | -37.64% |
| Dec 31, 2021 | 992.58M | 570.87M | 135.37% |
| Dec 31, 2020 | 421.71M | 389.18M | 1,196.46% |
| Dec 31, 2019 | 32.53M | 11.18M | 52.35% |
| Dec 31, 2018 | 21.35M | 2.62M | 13.99% |
| Dec 31, 2017 | 18.73M | 454.00K | 2.48% |
| Dec 31, 2016 | 18.28M | 8.70M | 90.85% |
| Dec 31, 2015 | 9.58M | 8.30M | 649.30% |
| Dec 31, 2014 | 1.28M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Myriad Genetics | 824.50M |
| NeoGenomics | 727.33M |
| OPKO Health | 606.88M |
| CareDx | 379.81M |
| Castle Biosciences | 344.23M |
| MDxHealth | 107.88M |
| Prenetics Global | 92.39M |
| Biodesix | 88.50M |
FLGT News
- 9 days ago - Fulgent Genetics, Inc. (FLGT) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 10 days ago - Fulgent Reports Fourth Quarter and Full Year 2025 Financial Results - Business Wire
- 25 days ago - Fulgent to Announce Fourth Quarter and Full Year 2025 Financial Results on Friday, February 27, 2026 - Business Wire
- 5 weeks ago - Fulgent Genetics: The Price Has Caught Up To Value, But I Still Like The Stock - Seeking Alpha
- 2 months ago - Fulgent Genetics Agrees to Acquire Bako Diagnostics and StrataDx - Business Wire
- 4 months ago - Fulgent Genetics, Inc. (FLGT) Presents at UBS Global Healthcare Conference 2025 Transcript - Seeking Alpha
- 4 months ago - Fulgent to Participate in Upcoming Conferences - Business Wire
- 4 months ago - Fulgent Genetics, Inc. (FLGT) Q3 2025 Earnings Call Transcript - Seeking Alpha